Cargando…

Usefulness of FRAIL Scale in Heart Valve Diseases

BACKGROUND: The frailty syndrome is a serious health problem for an aging population. The occurrence of frailty in the group of symptomatic patients undergoing heart valve surgery may have additional clinical implications. The predictive ability of the FRAIL scale in patients undergoing heart valve...

Descripción completa

Detalles Bibliográficos
Autores principales: Duchnowski, Piotr, Szymański, Piotr, Kuśmierczyk, Mariusz, Hryniewiecki, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358089/
https://www.ncbi.nlm.nih.gov/pubmed/32753858
http://dx.doi.org/10.2147/CIA.S239054
_version_ 1783558787056009216
author Duchnowski, Piotr
Szymański, Piotr
Kuśmierczyk, Mariusz
Hryniewiecki, Tomasz
author_facet Duchnowski, Piotr
Szymański, Piotr
Kuśmierczyk, Mariusz
Hryniewiecki, Tomasz
author_sort Duchnowski, Piotr
collection PubMed
description BACKGROUND: The frailty syndrome is a serious health problem for an aging population. The occurrence of frailty in the group of symptomatic patients undergoing heart valve surgery may have additional clinical implications. The predictive ability of the FRAIL scale in patients undergoing heart valve surgery during a 30-day follow-up has not yet been described. PATIENTS AND METHODS: A prospective study was conducted on a group of consecutive patients with hemodynamically significant valve disease (aortic stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation) that underwent elective valve surgery in 2014–2019. The primary endpoint was 30-day mortality. Univariate analysis, followed by multivariate regression analysis, was performed. RESULTS: The study group included 672 consecutive patients (aortic valve stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation) who underwent replacement or repair of the valve. Twenty-five patients died during the 30-day follow-up. At multivariate analysis, FRAIL scale result (OR 2.802; 95% CI 1.275–6.157; p=0.01) and red cell distribution width (RDW) (OR 1.810; 95% CI 1.181–2.775; p=0.006) remained independent predictors of the primary endpoint. CONCLUSION: The presented study showed the predictive ability of the FRAIL scale result in patients undergoing heart valve surgery for 30-day mortality.
format Online
Article
Text
id pubmed-7358089
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73580892020-08-03 Usefulness of FRAIL Scale in Heart Valve Diseases Duchnowski, Piotr Szymański, Piotr Kuśmierczyk, Mariusz Hryniewiecki, Tomasz Clin Interv Aging Original Research BACKGROUND: The frailty syndrome is a serious health problem for an aging population. The occurrence of frailty in the group of symptomatic patients undergoing heart valve surgery may have additional clinical implications. The predictive ability of the FRAIL scale in patients undergoing heart valve surgery during a 30-day follow-up has not yet been described. PATIENTS AND METHODS: A prospective study was conducted on a group of consecutive patients with hemodynamically significant valve disease (aortic stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation) that underwent elective valve surgery in 2014–2019. The primary endpoint was 30-day mortality. Univariate analysis, followed by multivariate regression analysis, was performed. RESULTS: The study group included 672 consecutive patients (aortic valve stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation) who underwent replacement or repair of the valve. Twenty-five patients died during the 30-day follow-up. At multivariate analysis, FRAIL scale result (OR 2.802; 95% CI 1.275–6.157; p=0.01) and red cell distribution width (RDW) (OR 1.810; 95% CI 1.181–2.775; p=0.006) remained independent predictors of the primary endpoint. CONCLUSION: The presented study showed the predictive ability of the FRAIL scale result in patients undergoing heart valve surgery for 30-day mortality. Dove 2020-07-09 /pmc/articles/PMC7358089/ /pubmed/32753858 http://dx.doi.org/10.2147/CIA.S239054 Text en © 2020 Duchnowski et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Duchnowski, Piotr
Szymański, Piotr
Kuśmierczyk, Mariusz
Hryniewiecki, Tomasz
Usefulness of FRAIL Scale in Heart Valve Diseases
title Usefulness of FRAIL Scale in Heart Valve Diseases
title_full Usefulness of FRAIL Scale in Heart Valve Diseases
title_fullStr Usefulness of FRAIL Scale in Heart Valve Diseases
title_full_unstemmed Usefulness of FRAIL Scale in Heart Valve Diseases
title_short Usefulness of FRAIL Scale in Heart Valve Diseases
title_sort usefulness of frail scale in heart valve diseases
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358089/
https://www.ncbi.nlm.nih.gov/pubmed/32753858
http://dx.doi.org/10.2147/CIA.S239054
work_keys_str_mv AT duchnowskipiotr usefulnessoffrailscaleinheartvalvediseases
AT szymanskipiotr usefulnessoffrailscaleinheartvalvediseases
AT kusmierczykmariusz usefulnessoffrailscaleinheartvalvediseases
AT hryniewieckitomasz usefulnessoffrailscaleinheartvalvediseases